Read about the latest insights in skin cancer care with a new whitepaper on advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. View the complimentary resource today!
In this feature interview with The Dermatologist, Aaron Drucker MD, ScM, FRCPC, discussed what the Skin Investigation Network is and how research priorities can optimize patient care.
In this feature interview with The Dermatologist, Aaron Drucker MD, ScM, FRCPC, discussed what the Skin Investigation Network is and how research priorities can optimize patient care.
On the second day of Dermatology Week 2023, Leigh Ann Pansch, MSN, FNP-BC, DCNP, highlighted the importance of understanding pigmented lesions in pediatric patients.
On the second day of Dermatology Week 2023, Leigh Ann Pansch, MSN, FNP-BC, DCNP, highlighted the importance of understanding pigmented lesions in pediatric patients.
Researchers aimed to investigate the prevalence and clinical characteristics of pruritus in patients with psoriasis, as well as the factors associated with high levels of itchiness.
Researchers aimed to investigate the prevalence and clinical characteristics of pruritus in patients with psoriasis, as well as the factors associated with high levels of itchiness.
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...